knowledge -WSS

knowledge

author：focus 2025-10-02 23:47:21 - browse：114

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： CDC director unscathed in first congressional testimony

hotspot

WSS

Organ aging and disease risk measured by new blood test

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

What don’t we know about an Alzheimer’s drug side effect?

FDA panel issues narrow recommendation for Covid vaccine booster doses

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Wikipedia

Alkermes shareholders re

Organ aging and disease risk measured by new blood test

Novavax promises a turnaround & Lilly roils the obesity market

American woman, child freed after being kidnapped in Haiti last month

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Will the market for weight loss drugs really reach $100 billion?

Sports medicine is finally prioritizing gender equality

UnitedHealth’s Optum accused of antitrust violations in California

23andMe had bad news about my health. I wish a person had delivered it

A biotech analyst on neuroscience, placebo effect, not over

knowledge

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Despite FDA concern, risk that CAR

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

How to use technology to prevent future drug shortages

Naloxone nonprofit donates 200,000 doses after FDA approval

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

hotspot

leisure time

hotspot

Wikipedia